Mostrar el registro sencillo del ítem
dc.contributor.author
Gomez Cherey, Juan Facundo
dc.contributor.author
Payalef, Sandra Noemi
dc.contributor.author
Fleider, Laura
dc.contributor.author
Reyes, Ana Paula
dc.contributor.author
Maldonado, Verónica Andrea
dc.contributor.author
Losada, Mirta Olga
dc.contributor.author
Chen, Xin
dc.contributor.author
Cardinal, Lucía Helena
dc.contributor.author
Wang, Youxiang
dc.contributor.author
Tatti, Silvio Alejandro
dc.contributor.author
Perazzi, Beatriz Elizabeth
dc.date.available
2024-05-02T13:34:31Z
dc.date.issued
2023-04
dc.identifier.citation
Gomez Cherey, Juan Facundo; Payalef, Sandra Noemi; Fleider, Laura; Reyes, Ana Paula; Maldonado, Verónica Andrea; et al.; Microbiota unbalance in relation to high-risk human papillomavirus cervical infection; BMJ Publishing Group; International Journal of Gynecological Cancer; 33; 4; 4-2023; 482-488
dc.identifier.issn
1525-1438
dc.identifier.uri
http://hdl.handle.net/11336/234389
dc.description.abstract
Objective To assess vaginal dysfunction using basic vaginal states and the presence of lactobacillary microbiota in patients with HPV infection with no squamous intraepithelial lesions (SIL), low-grade squamous intraepithelial lesion (L-SIL) and high-grade squamous intraepithelial lesion (H-SIL) or squamous cell carcinoma compared to a control group (HPV-negative). To establish the prevalence of bacterial vaginosis, candidiasis and trichomoniasis in the different age groups and to characterize the species of lactobacilli according to type of lesion.Methods Cross-sectional study of patients who underwent clinical examination and collection of vaginal fornixes to study basic vaginal states and culture. Species identification of lactobacilli was performed by mass spectrometry. The Chi-square and Fisher´s test were used. p<0.05 was considered significant. High-risk viral types were determined using a multiplex real time PCR test.Results: A total of 741 patients were analyzed and divided into 3 age groups: Group 1, aged 18 to 24 years (n=138), Group 2, aged 25 to 50 years (n=456) and Group 3, aged over 50 years (n=147). All groups were further divided into HPV-negative (Control), HPV-positive without lesion, L-SIL, H-SIL/squamous cell carcinoma. The prevalence of unbalance basic vaginal states in H-SIL/squamous cell carcinoma was 72.7% (p=0.03) in Group 1, 53.1% (p=0.05) in Group 2, and no cases of unbalance were detected in Group 3. The prevalence of bacterial vaginosis in the H-SIL/squamous cell carcinoma in group 1 was 54.5% and in group 2 was 43.7%. Patients with H-SIL/squamous cell carcinoma had a prevalence of 21.4% of Lactobacillus crispatus, 42.9% of L. jensenii and 14.3% of L. iners.Conclusions: A greater unbalance of vaginal microbiota was observed in patients with squamous intraepithelial lesions (SIL), especially in H-SIL/squamous cell carcinoma. In this group, an increase of L. jensenii and L. iners compared to control was found. L. crispatus had similar prevalence to control group. It is important to characterize the lactobacilli species since the unbalance alters the vaginal microenvironment and acts as a cofactor in the persistence of HPV infection.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
BMJ Publishing Group
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
MICROBIOTA UNBALANCE
dc.subject
HIGH-RISK HPV
dc.subject
CERVICAL INFECTION
dc.subject.classification
Enfermedades Infecciosas
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Microbiota unbalance in relation to high-risk human papillomavirus cervical infection
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-05-02T11:22:29Z
dc.journal.volume
33
dc.journal.number
4
dc.journal.pagination
482-488
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Philadelphia
dc.description.fil
Fil: Gomez Cherey, Juan Facundo. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Payalef, Sandra Noemi. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Reyes, Ana Paula. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina
dc.description.fil
Fil: Maldonado, Verónica Andrea. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Losada, Mirta Olga. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Tecnología Farmacéutica; Argentina
dc.description.fil
Fil: Chen, Xin. No especifíca;
dc.description.fil
Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Wang, Youxiang. No especifíca;
dc.description.fil
Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.description.fil
Fil: Perazzi, Beatriz Elizabeth. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.journal.title
International Journal of Gynecological Cancer
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://ijgc.bmj.com/content/early/2023/01/04/ijgc-2022-003760.citation-tools
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1136/ijgc-2022-003760
Archivos asociados